CN
中
英
Learn more
Ensure drug safety and safeguard human health.
Learn more

Product Center

-01

Process Additive Residue Detection

Learn more
-02

Content and Titer Detection

Learn more
-03

Host Cell Protein Residue Detection

Learn more
-04

Detection of Residual Nucleic Acids in Host Cells

Learn more
-05

Safety Detection

Learn more

Product solutions

  • 01antibody
    Quality control of antibody-based drugs covers multiple key aspects, including structural integrity, purity and impurity analysis, activity detection, and stability evaluation.
    Learn more
  • 02vaccine
    Quality control of vaccine drugs should target samples at different stages and cover aspects such as structural characteristics, purity, impurities, and biological activity. Multiple detection methods should be employed, and attention should be paid to the impact of sample processing on the results.
    Learn more
  • 03cell therapy
    Quality control items for cell therapy drugs include appearance, viral vector morphology, identification, integration characteristics (if applicable), viral vector titer, biological activity, purity, and impurities (such as replicative viruses, residual risk components, and exogenous factors).
    Learn more
  • 04gene therapy
    The quality control items for gene therapy drugs should be determined according to the product type, mechanism of action, and production process. Common quality research items include: identification, structural analysis, biological activity, purity, impurities, content, transfection/infection efficiency, general physical and chemical properties, etc.
    Learn more
01antibody
Quality control of antibody-based drugs covers multiple key aspects, including structural integrity, purity and impurity analysis, activity detection, and stability evaluation.
Learn more
02vaccine
Quality control of vaccine drugs should target samples at different stages and cover aspects such as structural characteristics, purity, impurities, and biological activity. Multiple detection methods should be employed, and attention should be paid to the impact of sample processing on the results.
Learn more
03cell therapy
Quality control items for cell therapy drugs include appearance, viral vector morphology, identification, integration characteristics (if applicable), viral vector titer, biological activity, purity, and impurities (such as replicative viruses, residual risk components, and exogenous factors).
Learn more
04gene therapy
The quality control items for gene therapy drugs should be determined according to the product type, mechanism of action, and production process. Common quality research items include: identification, structural analysis, biological activity, purity, impurities, content, transfection/infection efficiency, general physical and chemical properties, etc.
Learn more
ABOUT US

Junyan Biotechnology (Shanxi) Co., Ltd. is deeply engaged in the field of quality control and testing for biological products. As a national high - tech enterprise, it provides one - stop solutions and technical services for global pharmaceutical enterprises. At present, its business covers multiple detection and customized services such as process impurity residue, content, host nucleic acid/protein residue, and safety. All products are independently developed and produced and managed in accordance with the requirements of the ISO13485 quality management system. So far, it has served more than 400 customers at home and abroad, helped many biological drugs go public, and won wide praise from customers.

Learn more
  • ISO13485
    International certification
  • HNTE
    China Certification
  • 400 +
    Service Enterprise
  • 100 +
    Assist customersIND
  • 50 +
    Enterprise intellectual property
  • 600 +
    Cleanroom floor area

News

Learn more
  • News